Oaktree Acquisition Corp. III Life Sciences
$10.63
-0.19%Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
High confidenceValuation multiple is elevated (P/E 35.4).
Valuation inputs: P/E 35.4, earnings yield +2.8%, momentum -0.2%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE +3.7%, ROIC -0.6%).
Profitability stack: net margin 0.0%, ROE +3.7%, ROIC -0.6%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +4.1%, momentum -0.2%, net margin 0.0%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Oaktree Acquisition Corp. III Life Sciences Market vs Earnings Trajectory
Loading price and EPS data...
Oaktree Acquisition Corp. III Life Sciences Fair Value Envelope
No Revenue Data
OACC has not reported any revenue values in the available annual periods.
Oaktree Acquisition Corp. III Life Sciences Profit Bridge
Profitability Analysis
No Gross Profit Margin Data
OACC has not reported any gross profit margin values in the available annual periods.
No Operating Profit Margin Data
OACC has not reported any operating profit margin values in the available annual periods.
No Net Profit Margin Data
OACC has not reported any net profit margin values in the available annual periods.
Oaktree Acquisition Corp. III Life Sciences Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Neutral working capital impact. Changes in current assets and liabilities balanced out.
Cash Flow Quality Insight
Cash flow concerns: Despite profitability, the company is burning cash. Review working capital management, CapEx levels, and sustainability of current operations.
Oaktree Acquisition Corp. III Life Sciences Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.
Debt-to-Equity Ratio
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Working Capital
Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.
Asset Composition
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
Financial Health Insight
Conservative with tight liquidity: Low debt is positive, but current ratio warrants attention. Consider whether the company is efficiently deploying its equity capital.
Oaktree Acquisition Corp. III Life Sciences Street Expectations Map
No Target Data
No analyst price targets available for oacc.
Oaktree Acquisition Corp. III Life Sciences Insider Positioning
During the last 12 months, there has been no insider trading activity reported for OACC.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
No buying activity
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.
Insider Participation
No insider trading activity reported from any insiders in the past year.
oacc Dividend History
Learning Layer
Related Guides
Build conviction on OACC by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.